Kyodo news agency reported that although the current 3rd dose vaccination is widely available to adults in Japan. But children in that age group are still allowed to receive only 2 doses of the vaccine.
Pfizer clinical trial data released in April showed that Booster vaccination increases the amount of antibodies that can inhibit the virus by 6 times when used in children 5-11 years of age approximately 6 months after the second dose of vaccine.
Pfizer said the vaccine was effective against the Omicron strain. and have not encountered any security issues.
The U.S. Food and Drug Administration (FDA) approved the use of Pfizer’s booster vaccine in children ages 5-11 in the United States in May.
Proofreading….Suree Silawong
